Clinical Trial Update: Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating empagliflozin in patients after acute myocardial infarction has completed with results posted, assessing cardiac function and heart fai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Medical University of Graz | Conditions: Acute Myocardial Infarction | Phase 3 | Status: COMPLETED | Results posted: 2024-08-22